Original Source(s)
Related Content
Tenecteplase Fails to Boost EVT Outcomes
Phase 3 stroke trial leaves open the possibility of clinically meaningful benefit or harm in selected late-window patients.
May 14, 2026
-
6 min
Tirofiban After Tenecteplase in Stroke
Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.
May 14, 2026
-
6 min
Lactate–Albumin Ratio Tied to TBI Mortality
Admission biomarker showed prognostic value alongside clinical scoring systems in pediatric intensive care
April 17, 2026
-
3 min